• 1. An apparatus for testing water by measurement of its electrical conductivity
  Analyst, 1912,37, 538-543
• 2. An atmosphere and light tuned highly diastereoselective synthesis of cyclobuta/penta[b]indoles from aniline-tethered alkylidenecyclopropanes with alkynes?
  Bo Cao,Yin Wei Chem. Commun., 2018,54, 2870-2873
• 3. An investigation of surface properties, local elastic modulus and interaction with simulated pulmonary surfactant of surface modified inhalable voriconazole dry powders using atomic force microscopy
  Michael Kappl,Paul M. Young,Daniela Traini,Sanyog Jain RSC Adv., 2016,6, 25789-25798
• 4. An approach to biodegradable star polymeric architectures using disulfide coupling?
  Jingquan Liu,Huiyun Liu,Zhongfan Jia,Volga Bulmus,Thomas P. Davis Chem. Commun., 2008, 6582-6584
• 5. An integrated process of CO2 capture and in situ hydrogenation to formate using a tunable ethoxyl-functionalized amidine and Rh/bisphosphine system?
  Yu-Nong Li,Liang-Nian He,Xian-Dong Lang,Xiao-Fang Liu,Shuai Zhang RSC Adv., 2014,4, 49995-50002

Chenodeoxycholic Acid-d5 (Major): A Comprehensive Overview

Chenodeoxycholic Acid-d5 (Major), also known by its CAS number 52840-12-7, is a derivative of chenodeoxycholic acid, a naturally occurring bile acid. This compound has gained significant attention in recent years due to its role in various biological processes and its applications in both research and therapeutic settings. The d5 designation indicates that this compound contains five deuterium atoms, which are often used in scientific studies to track molecular behavior through techniques such as mass spectrometry and nuclear magnetic resonance (NMR) spectroscopy.

Bile acids, including chenodeoxycholic acid, play a critical role in lipid metabolism, digestion, and overall liver function. The introduction of deuterium into the molecular structure of chenodeoxycholic acid-d5 allows researchers to study the stereochemistry and metabolic pathways of bile acids with greater precision. Recent studies have highlighted the importance of bile acids in regulating energy expenditure, glucose metabolism, and gut microbiota composition. These findings underscore the potential of chenodeoxycholic acid-d5 as a tool for understanding the intricate mechanisms underlying metabolic disorders such as obesity and type 2 diabetes.

In the context of drug development, chenodeoxycholic acid-d5 has been utilized as a stable isotope for pharmacokinetic studies. By incorporating deuterium into the molecule, researchers can accurately trace the absorption, distribution, metabolism, and excretion (ADME) profiles of bile acids within the body. This information is invaluable for optimizing drug delivery systems and assessing the efficacy of potential therapeutic agents targeting bile acid pathways.

Recent advancements in mass spectrometry techniques have further enhanced the utility of chenodeoxycholic acid-d5 in metabolomics research. High-resolution mass spectrometry (HRMS) coupled with tandem MS has enabled precise identification and quantification of bile acids in complex biological matrices. These methods have been instrumental in elucidating the role of bile acids in chronic liver diseases such as non-alcoholic fatty liver disease (NAFLD) and cirrhosis. Studies have shown that altered bile acid metabolism is closely associated with disease progression, making chenodeoxycholic acid-d5 a valuable tool for investigating therapeutic interventions.

The application of chenodeoxycholic acid-d5 extends beyond basic research into clinical diagnostics. In diagnostic settings, this compound is used as an internal standard for measuring endogenous bile acid levels in patients with liver dysfunction or gastrointestinal disorders. Accurate quantification of bile acids is essential for diagnosing conditions such as primary biliary cholangitis (PBC) and cholestasis. The use of deuterated standards ensures high sensitivity and specificity in these assays, providing clinicians with reliable data for diagnosis and treatment monitoring.

Moreover, chenodeoxycholic acid-d5 has been employed in preclinical studies to evaluate the efficacy of novel drugs targeting bile acid receptors. The farnesoid X receptor (FXR) and the G protein-coupled receptor 19 (TGR5) are key targets for modulating bile acid signaling pathways. By using chenodeoxycholic acid-d5, researchers can assess how these receptors regulate lipid metabolism and inflammation at a molecular level. This knowledge is critical for developing drugs that can address unmet medical needs in metabolic diseases.

In summary, Chenodeoxycholic Acid-d5 (Major) is a versatile compound with significant implications for both research and clinical applications. Its unique properties as a deuterated bile acid make it an indispensable tool for studying metabolic pathways, developing therapeutic agents, and improving diagnostic accuracy. As advancements in analytical techniques continue to unfold, the role of chenodeoxycholic acid-d5 in advancing our understanding of human health and disease is likely to expand further.

• 474-25-9(Chenodeoxycholic acid)
• 128-13-2(Ursodeoxycholic acid)
• 434-13-9(Lithocholic acid)
• 459789-99-2(Obeticholic acid)
• 112076-61-6(Deoxycholic acid-d)
• 81-25-4(Cholic acid)
• 83-44-3(Deoxycholic acid)
• 83-49-8(Hyodeoxycholic acid)
• 132465-11-3(CDC)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)